Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxia-regulated differentiation: let's step it up a Notch.

Richard C A Sainson1, Adrian L Harris

  • 1Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK. richard.sainson@imm.ox.ac.uk

Trends in Molecular Medicine
|March 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies.

Journal for immunotherapy of cancer·2026
Same author

IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers.

Cancer discovery·2026
Same author

Generating exosome subtypes: diverse membrane origins and mergers.

Trends in cell biology·2026
Same author

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.

Cancer research·2026
Same author

Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nature medicine·2026
Same author

A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.

Communications medicine·2025
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Hypoxia blocks cell differentiation by regulating Notch signaling. Hypoxia-inducible factor-1alpha interacts with Notch intracellular domain, activating target gene transcription, offering new cancer research avenues.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • Hypoxia, low oxygen, is linked to adult diseases like cancer.
  • Hypoxia also plays a physiological role in cell differentiation during development.
  • Understanding hypoxia's molecular mechanisms is crucial for disease research.

Purpose of the Study:

  • To investigate the molecular mechanisms of hypoxia-regulated cell fate.
  • To characterize how hypoxia influences cell differentiation pathways.

Main Methods:

  • Investigated the interaction between hypoxia-inducible factor (HIF)-1alpha and Notch signaling.
  • Analyzed the transcriptional activity of Notch targets under hypoxic conditions.

Main Results:

Related Experiment Videos

  • Demonstrated that hypoxia inhibits cell differentiation.
  • Showed that HIF-1alpha interacts with Notch intracellular domain (NIC).
  • Confirmed that HIF-1alpha and NIC act synergistically to activate Notch target gene transcription.

Conclusions:

  • Established a novel crosstalk between hypoxia and Notch signaling pathways.
  • Identified a key mechanism by which hypoxia regulates cell differentiation.
  • Opened new avenues for cancer research targeting hypoxia- and Notch-deregulated pathways.